Robin Toft
CIK: 0001815565
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
T2 Biosystems, Inc.
Discretionary Trading P&L
Holdings
Robin Toft files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO). Signal8 holds 1 reported Form 4/5 transaction by Robin Toft since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in TTOO, dated Nov 4, 2024.
About Toft Robin
Toft Robin (SEC CIK 0001815565) files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO).
Signal8 holds 1 ownership filing by Toft Robin, a Form 4, filed on Jan 2, 2025. Those filings report 1 transaction, the latest on Nov 4, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Toft Robin's filings is in LEXINGTON, MA.
Recent filings by Toft Robin
- Nov 4, 2024: Grant or award of TTOO derivative securities (Form 4, code A).
Other insiders filing for T2 Biosystems, Inc. (TTOO)
- LIEBMAN SEYMOUR, Director
- Giffin Brett A., Chief Commercial Officer
- Adams Laura Lee, Director
- CUMMING JOHN W, Director
- Gibbs Michael Terrence, General Counsel
- Saunders Ninfa, Director